NCT07048886Not yet recruitingPhase 4
Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
Source: ClinicalTrials.gov · Last updated 3 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- First submitted
- 15 Jun 2025
- Start date
- 15 Jul 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Center for Sight Las Vegas
- Diseases
- Glaucoma
- NCT number
- NCT07048886
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 68
- From 15 Jul 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior Selective Laser Trabeculoplasty (SLT) within 18 months of surgery
- Anticipated use of intra-ocular or topical steroids not associated with the study protocol
Other illness
- History of intraocular surgery except for uneventful refractive surgery or uncomplicated cataract surgery and hydrus microstent implantation
- Secondary glaucoma excluding pseudoexfoliation and pigmentary dispersion syndrome
- Allergy or intolerance to Rocklatan
- History of corneal edema, or corneal disease or dystrophy
- Current or history of intra-ocular infection or inflammation
- History of retinal diseases that could affect diagnostic testing
- Any condition in the opinion in the investigator that would potentially confound the results of the study
Other
- Severe Open Angle Glaucoma
- Narrow angles, other angle abnormalities or angle closure glaucoma
- Pregnant, breastfeeding or planning to become pregnant during the study
Who the study is looking for
- Age 40 years and older
- Subjects who have mild to moderate Open Angle Glaucoma (OAG)
- Subjects who have undergone uncomplicated cataract surgery and Hydrus microstent implantation \> 3 months prior to screening and within the last 2 years
- Post-Hydrus subjects on 0-2 ocular hypotensive medication classes who can safely washout (if on ocular hypotensive medications)
- Unmedicated or washed out IOP range between 16-26 mmHg
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center for Sight Coordinator of this site? Confirm its status | Las Vegas | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.